CUX1/Wnt signaling regulates Epithelial Mesenchymal Transition in EBV infected epithelial cells

Experimental Cell Research

Volumn 315, Issue 11, 2009, Pages 1819-1831

  Malizia, Andrea P ^a   Lacey, Noreen ^a   Walls, Dermot ^b   Egan, Jim J ^c   Doran, Peter P ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

CUX1; EBV; EMT; Idiopathic Pulmonary Fibrosis; Wnt5b

Indexed keywords

RETINOIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CUX1; UNCLASSIFIED DRUG; WNT PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; MESENCHYME CELL; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 4;

EID: 65749101004     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.04.001     Document Type: Article

References (49)

1. Selman M., and Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3 (2002) 3
2. Stewart J.P., Egan J.J., Ross A.J., Kelly B.J., Lok S.S., Hasleton P.S., and Woodcock A.A. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 159 (1999) 1336-1341
3. Tang Y.W., Johnson J.E., Browning P.J., Cruz-Gervis R.A., Davis A., Graham B.S., Brighman K.L., Oates Jr. J.A., Loyd J.E., and Stecenko A.A. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Microbiol. 41 (2003) 2633-2640
4. Tsukamoto K., Hayakawa H., Sato A., Chida K., Nakamura H., and Miura K. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 55 (2000) 958-961
5. Wangoo A., Shaw R.J., Diss T.C., Farrell P.J., du Bois R.M., and Nicholson A.G. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax 10 (1997) 888-891
6. Zamò A., Poletti V., Reghellin D., Montagna L., Pedron S., Piccoli P., and Chilosi M. HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2 (2005) 123-128
7. Sporn M.B., and Roberts A.B. Transforming growth factor-beta: recent progress and new challenges. J. Cell Biol. 119 (1992) 1017-1021
8. Fukuda M., Ikuta K., Yanagihara K., Tajima M., Kuratsune H., Kurata T., and Sairenji T. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Virology 288 (2001) 109-118
9. Lu C.C., Jeng Y.Y., Tsai C.H., Liu M.Y., Yeh S.W., Hsu T.Y., and Chen M.R. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 2 (2006) 358-372
10. Desmouliere A., Darbyand I.A., and Gabbiani G. Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 83 (2003) 1689-1707
11. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112 (2003) 1776-1784
12. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15 (2004) 1-12
13. Ozdamar B., Bose R., Barrios-Rodiles M., Wang H.R., Zhang Y., and Wrana J.L. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307 (2005) 1603-1609
14. Zavadil J., Bitzer M., Liang D., Yang Y.C., Massimi A., Kneitz S., Piek E., and Bottinger E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6686-6691
15. Kasai H., Allen J.T., Mason R.M., Kamimura T., and Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6 (2005) 56
16. Willis B.C., Liebler J.M., Luby-Phelps K., Nicholson A.G., Crandall E.D., du Bois R.M., and Borok Z. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166 (2005) 1321-1332
17. Davies M., Robinson M., Smith E., Huntley S., Prime S., and Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signaling pathways. J. Cell. Biochem. 95 (2005) 918-931
18. Santibanez J.F. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett. 22 (2006) 5385-5391
19. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 270 (2001) 1-15
20. Michl P., Ramjaun A.R., Pardo O.E., Warne P.H., Wagner M., Poulsom R., D'Arrigo C., Ryde K., Menke A., Gress T., and Downward J. CUX1 is a target of TGFbeta signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7 (2005) 521-532
21. Truscott M., Raynal L., Premdas P., Goulet B., Leduy L., Berube G., and Nepveu A. CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter. Mol. Cell. Biol. 23 (2003) 3013-3028
22. Vanden Heuvel G.B., Brantley J.G., Alcalay N.I., Sharma M., Kemeny G., Warolin J., Ledford A.W., and Pinson D.M. Hepatomegaly in transgenic mice expressing the homeobox gene Cux-1. Mol. Carcinog. 43 (2005) 18-30
23. Brantley J.G., Sharma M., Alcalay N.I., and Heuvel G.B. Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis. Kidney Int. 4 (2003) 1240-1248
24. Imai S., Nisiwkawa J., and Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72 (1998) 4371-4378
25. Keating D.T., Sadlier D.M., Patricelli A., Smith S.M., Walls D., Egan J.J., and Doran P.P. Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells. Respir. Res. 7 (2006) 114
26. Malizia A.P., Keating D.T., Smith S.M., Walls D., Doran P.P., and Egan J.J. Alveolar epithelial cell injury with Epstein Barr virus upregulates TGFβ1 expression. Am. J. Physiol., Lung Cell. Mol. Physiol. 3 (2008) L451-L460
27. Kieran N.E., Doran P.P., Connolly S.B., Greenan M.C., Higgins D.F., Leonard M., Godson C., Taylor C.T., Henger A., Kretzler M., Burne M.J., Rabb H., and Brady H.R. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64 (2003) 480-492
28. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
29. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14863-14868
30. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4 (2003) P3
31. Ho C.H., Hsu C.F., Fong P.F., Tai S.K., Hsieh S.L., and Chen C.J. Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter. J. Virol. 81 (2007) 4837-4847
32. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., and Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21 (2005) 2933-2942
33. J. Schug, G.C. Overton, (1997) Technical Report CBIL-TR-1997-1001-v0.0 Computational Biology and Informatics Laboratory School of Medicine. University of Pennsylvania. (www.cbil.upenn.edu/cgi-bin/tess/tess).
34. Chen S.Y., Lu J., Shih Y.C., and Tsai C.H. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J. Virol. 76 (2002) 9556-9561
35. Iozzo R.V., Eichstetter I., and Danielson K.G. Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res. 55 (1995) 3495-3499
36. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M., and Trent J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1 (2002) 279-288
37. Königshoff M., Balsara N., Pfaff EM., Kramer M., Chrobak I., Seeger W., and Eickelberg O. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS ONE 5 (2008) e2142
38. Selman M., Pardo A., and Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?. PLoS Med. 3 (2008) e62
39. Jiang F., Parsons C.J., and Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J. Hepatol. 45 (2006) 401-409
40. Katoh M., and Katoh M. Comparative genomics on Wnt5a and Wnt5b genes. Int. J. Mol. Med. 15 (2005) 749-753
41. Ang S.J., Stump R.J., Lovicu F.J., and McAvoy J.W. Spatial and temporal expression of Wnt and Dickkopf genes during murine lens development. Gene Expr. Patterns 4 (2004) 289-295
42. Hayward S.D., Liu J., and Fujimuro M. Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Sci. STKE 335 (2006) re4
43. Mangioni S., Vigano P., Lattuada D., Abbiati A., Vignali M., and Di Blasio A.M. Overexpression of the Wnt5b gene in leiomyoma cells: implications for a role of the Wnt signaling pathway in the uterine benign tumor. J. Endocrinol. Metab. 90 (2005) 5349-5355
44. Saitoh T., and Katoh M. Expression and regulation of Wnt5A and Wnt5B in human cancer: up-regulation of Wnt5A by TNFalpha in MKN45 cells and up-regulation of Wnt5B by beta-estradiol in MCF-7 cells. Int. J. Mol. Med. 10 (2002) 345-349
45. Ripka S., Konig A., Buchholz M., Wagner M., Sipos B., Gunter Kloppel G., Downward J., Gress T.M., and Michl P. WNT5A - target of CUX1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 6 (2007) 1178-1187
46. Horikawa T., Yang J., Kondo S., Yoshizaki T., Joab I., Furukawa M., and Pagano J.S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 5 (2007) 1970-1978
47. Chilosi M., Poletti V., Zamo A., Lestani M., Montagna L., Piccoli P., Pedron S., Mertaso M., Scarpa A., Murer B., Cancellieri A., Maestro R., Semenzato G., and Doglioni C. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 162 (2003) 1495-1502
48. He X. A Wnt-Wnt situation. Dev. Cell. 4 (2003) 791-797
49. Tabata C., Kadokawa Y., Tabata R., Takahashi M., Okoshi K., Sakai Y., Mishima M., and Kubo H. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 12 (2006) 1352-1360